Por favor, use este identificador para citar o enlazar este ítem: https://saber.ucv.ve/jspui/handle/10872/1697
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorMuth, Mathias-
dc.contributor.authorHoerr, Verena-
dc.contributor.authorGlaser, Melanie-
dc.contributor.authorPonte-Sucre, Alicia-
dc.contributor.authorMoll, Heidrun-
dc.contributor.authorStich, August-
dc.contributor.authorHolzgrabe, Ulrike-
dc.date.accessioned2012-08-23T17:08:47Z-
dc.date.available2012-08-23T17:08:47Z-
dc.date.issued2012-08-23-
dc.identifier.issn0960-894X-
dc.identifier.urihttp://hdl.handle.net/10872/1697-
dc.description.abstractSleeping sickness caused by Trypanosoma brucei gambiense and rhodesiense is fatal if left untreated. Due to the toxicity of drugs currently used and the emerging resistance against these drugs new lead compounds are urgently needed. Within the frame of a broad screening program for drugs with antitrypanosomal activity, some highly potent tertiary and quaternary mono- and bisnaphthalimides being active in the lower micromolar and nanomolar range of concentration have been identified. These compounds are easily available via a two- or three-step microwave-driven synthesis with high yield.es_VE
dc.description.sponsorshipDeutsche Forschungsgemeinschaft, National Institute of Healthes_VE
dc.language.isoen_USes_VE
dc.relation.ispartofseriesBioorganic Medicinal Chemistry Letters;17: 1590-1593, 2007-
dc.subjectSleeping sicknesses_VE
dc.subjectTrypanosoma bruceies_VE
dc.subjectquaternary and tertiary naphthalimideses_VE
dc.titleAntitrypanosomal Activity of Quaternary Naphthalimide Derivativeses_VE
dc.typeArticlees_VE
Aparece en las colecciones: Artículos Publicados

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Muth et al., BMC 2007.pdf136.32 kBAdobe PDFVisualizar/Abrir


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.